TY - JOUR
T1 - Alpha Interferon for Induction of Remission in Hairy-Cell Leukemia
AU - Quesada, Jorge R.
AU - Reuben, James
AU - Manning, John T.
AU - Hersh, Evan M.
AU - Gutterman, Jordan U.
PY - 1984/1/5
Y1 - 1984/1/5
N2 - We treated seven patients who had progressive hairy-cell leukemia with daily doses of 3 million units of partially pure alpha (leukocyte) interferon by the intramuscular route. Three patients had a complete remission, and four had a partial remission, according to strict criteria for a response. After treatment, bone-marrow aspirates showed an absence of leukemia cells in three patients and 5 per cent or fewer in three others. Normalization of subnormal peripheral-blood values occurred in six of six patients with anemia, in seven of seven with granulocytopenia, and in four of four with thrombocytopenia. Remissions have been maintained for over 6 to over 10 months. Alpha interferon appears to be highly effective in patients with hairy-cell leukemia.
AB - We treated seven patients who had progressive hairy-cell leukemia with daily doses of 3 million units of partially pure alpha (leukocyte) interferon by the intramuscular route. Three patients had a complete remission, and four had a partial remission, according to strict criteria for a response. After treatment, bone-marrow aspirates showed an absence of leukemia cells in three patients and 5 per cent or fewer in three others. Normalization of subnormal peripheral-blood values occurred in six of six patients with anemia, in seven of seven with granulocytopenia, and in four of four with thrombocytopenia. Remissions have been maintained for over 6 to over 10 months. Alpha interferon appears to be highly effective in patients with hairy-cell leukemia.
UR - http://www.scopus.com/inward/record.url?scp=0021345092&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021345092&partnerID=8YFLogxK
U2 - 10.1056/NEJM198401053100104
DO - 10.1056/NEJM198401053100104
M3 - Article
C2 - 6689734
AN - SCOPUS:0021345092
SN - 0028-4793
VL - 310
SP - 15
EP - 18
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 1
ER -